We have replaced our microdermabrasion system with the new SilkPeel® Dermalinfusion™ process. With it, acne and acne scarring, fine lines and wrinkles, uneven skin tones and hyperpigmentation, photodamage, rough or dry dehydrated skin, superficial scars and Keratosis Pilaris can all be treated. Where the older technology used a controlled spray of fine grit, we now choose one or more of a variety of liquids during the process. The treatment is more comfortable and allows for topical treatments to be infused directly to the skin. Either the face or the body can be treated.
Similar to microdermabrasion, the SilkPeel Dermalinfusion System combines non-invasive exfoliation with deep delivery of patient-specific solutions directly to the skin without the use of crystals or chemical exfoliants. During the procedure, one or more of a selection of solutions is infused. For example, in treating a condition like melasma we use a bleaching agent called Lumixyl®, a non-toxic, non-irritating, synthetic peptide technology that is clinically shown to significantly improve the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone. Developed by dermatological researchers at Stanford University, Lumixyl’s Decapeptide-12 is the only peptide shown to measurably aid the skin in restraining tyrosinase, the enzyme responsible for initiating the overproduction of melanin that can cause uneven pigmentation and dark spots. This method enhances transdermal delivery of topical ingredients to the skin and facilitates the penetration of corrective products through the epidermis. Results may or may not be permanent: patients prone to hyperpigmentation and melasma are often susceptible to recurrence.